This episode of the “Empowering Providers to Empower Patients” (EPEP) podcast features Dr. Andrew Laccetti of NYU Langone Health discussing the rapidly evolving field of bladder cancer care. Dr. Laccetti explores what makes bladder cancer unique among genitourinary cancers, highlights recent innovations,including combination therapies achieving 70% response rates in advanced cases and shares strategies to empower patients through clear communication and decision-making support. Key Topics in ...
All content for Empowered! is the property of Patient Empowerment Network and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
This episode of the “Empowering Providers to Empower Patients” (EPEP) podcast features Dr. Andrew Laccetti of NYU Langone Health discussing the rapidly evolving field of bladder cancer care. Dr. Laccetti explores what makes bladder cancer unique among genitourinary cancers, highlights recent innovations,including combination therapies achieving 70% response rates in advanced cases and shares strategies to empower patients through clear communication and decision-making support. Key Topics in ...
HCP Roundtable: Critical Clinical Trial Conversations in the Expanding Myeloma Landscape
Empowered!
32 minutes
1 year ago
HCP Roundtable: Critical Clinical Trial Conversations in the Expanding Myeloma Landscape
Treatment options for multiple myeloma have increased substantially, mainly attributed to advancements in clinical trials. More than ever, HCPs having conversations about trials is critical. Given that underrepresented communities bear a disproportionate burden of multiple myeloma, it becomes imperative to shift this paradigm.What are the optimal approaches to initiate these conversations early in the patient journey? How should HCPs effectively communicate information about clinical trials t...
Empowered!
This episode of the “Empowering Providers to Empower Patients” (EPEP) podcast features Dr. Andrew Laccetti of NYU Langone Health discussing the rapidly evolving field of bladder cancer care. Dr. Laccetti explores what makes bladder cancer unique among genitourinary cancers, highlights recent innovations,including combination therapies achieving 70% response rates in advanced cases and shares strategies to empower patients through clear communication and decision-making support. Key Topics in ...
